ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Exogenous spermidine alleviates diabetic cardiomyopathy via suppressing reactive oxygen species, endoplasmic reticulum stress, and Pannexin-1-mediated ferroptosis

Sun, Jian; Xu, Jiyu; Liu, Yong; Lin, Yitong; Wang, Fengge; Han, Yue; Zhang, Shumin; Gao, Xiaoyan; Xu, Changqing; Yuan, Hui*南方医科大学; 哈尔滨医科大学; 5
BIOMOLECULES AND BIOMEDICINE2023DOI: 10.17305/bb.2022.8846
6被引8阅读
引用收藏
分享

摘要

Diabetic cardiomyopathy (DCM) is a serious complication and death cause of diabetes mellitus (DM). Recent cardiology studies suggest that spermidine (SPD) has cardioprotective effects. Here, we verified the hypothesis of SPD's protective effects on DCM. Therefore, db/db mice and primary neonatal mouse cardiomyocytes were used to observe the effects of SPD. Immunoblotting showed that ornithine decarboxylase (ODC) and SPD/spermine N1-acetyltransferase (SSAT) were downregulated and upregulated in the myocardium of db/db mice, respectively. We found that diabetic mice showed cardiac dysfunction in 12 weeks. Conversely, exogenous SPD could improve cardiac functions and reduce the deposition of collagens, myocardial damage, reactive oxygen species (ROS) levels, and endoplasmic reticulum stress (ERS) in diabetic mouse hearts. Our results also demonstrated that cardiomyocytes displayed ferroptosis and then activated Pannexin-1 expression, which resulted in the increase of the extracellular adenosine triphosphate (ATP). Subsequently, increased ATP as a paracrine molecule combined to purinergic receptor P2X7 to activate ERK1/2 signaling pathway in cardiomyocytes and activated NCOA4-mediated ferroptinophagy to promote lipid peroxidation and ferroptosis. Interestingly, SPD could reverse these molecular processes. Our findings indicate an important new mechanism for DCM and suggest that SPD has potential applicability to protect against deterioration of cardiac function with DCM.

学科与关键词

关键词
Diabetic cardiomyopathy (DCM)Spermidine (SPD)ferroptosisPannexin-1
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
BIOMOLECULES AND BIOMEDICINE
发表日期
2023
卷期
第 23 卷, 第 5 期
页码
825-837
DOI
10.17305/bb.2022.8846
成果收录
SCIE
资助标注
Basic Scientific Research Business Research Project of Heilongjiang [2021- KYYWF-0466]

作者

  • S

    Sun, Jian (第一作者)

    mudanjiang med univ

  • X

    Xu, Jiyu

    mudanjiang med univ

查看全部 10 位作者收起作者
  • L

    Liu, Yong

    mudanjiang med univ

  • L

    Lin, Yitong

    mudanjiang med univ

  • W

    Wang, Fengge

    5 · southern med univ

  • H

    Han, Yue

    mudanjiang med univ

  • Z

    Zhang, Shumin

    mudanjiang med univ

  • G

    Gao, Xiaoyan

    mudanjiang med univ

  • X

    Xu, Changqing

    harbin med univ

  • Y

    Yuan, Hui (通讯)

    mudanjiang med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417